Pharma R&D Today
Ideas and Insight supporting all stages of Drug Discovery & Development
Wearables in Clinical Trials: Many Benefits, and One Big Challenge
Posted on July 19th, 2017 by Tim Hoctor in Pharma R&D
The rapid development of wearable technology has the power to be a game-changer in many areas, including pharmaceutical R&D. Its most obvious use for pharma is in clinical trials, where recruiting is a frequent challenge, as is getting study participants to adhere to their therapeutic regime. Wearables can help with both of these problems, first by collecting data remotely (and therefore freeing participants from having to report on site) and then by providing reminders so patients don’t forget to take their medication.
These capabilities stand to save companies huge amounts of money by increasing the efficiency of costly and lengthy clinical trials. The ability to easily collect all of this patient data is particularly impressive and creates great opportunity. At the same time, though, it creates a very big problem: How do you manage and analyze all of that data, once it’s collected? At this point, the mechanism for gathering useful data has outpaced the ability to read and interpret it. That task can’t just be left to a computer – it requires scientific minds to interpret it.
I recently published a feature on this “wearable revolution” for PharmaTimes. Click here to read the full article and learn more.
All opinions shared in this post are the author’s own.
R&D Solutions for Pharma & Life SciencesWe're happy to discuss your needs and show you how Elsevier's Solution can help.
Vice President, Life Science Solutions Services
- A Systems Thinking Approach for Pharma
- Global networks form to take on the problem of drug-induced liver injury (DILI)
- Infographic: Elsevier’s Professional Services team provides COVID-19 insights
- Webinar: Accelerating drug discovery by building and turning high-quality data into actionable insights
- Personal Health Train initiative gives researchers data access FAIRly